Paul Sargos, Radiation Oncologist, Head of the radiation oncology department at Bergonié Institute, shared a post on X:
“JUST OUT in EUO, New paper challenging a dogma.
MUST READ: Constance Huck has done a great job to show that CIS is not always a contra-indication for Trimodal Therapy in the management of MIBC.
Thanks to all co-authors for their input!”
Title: Radiation Therapy in the Management of Muscle-invasive Bladder Cancer with Carcinoma in Situ: Still a No Go?
Authors: Constance Huck, Vérane Achard, Jason Efstathiou, Julien Van Damme, Alexandre R. Zlotta, Evanguelos Xylinas, Ananya Choudhury, Morgan Rouprêt, Bertrand Tombal, Paul Sargos
Read OncoDaily’s Special Article: “Bladder Cancer Cure Rate: What Patients Need to Know in 2025”
